tiprankstipranks
Vir Biotechnology holds a virtual investor update
PremiumThe FlyVir Biotechnology holds a virtual investor update
1M ago
Vir Biotechnology announces results from SOLSTICE  trial
Premium
The Fly
Vir Biotechnology announces results from SOLSTICE trial
1M ago
Vir Biotechnology gets positive opinion on orphan drug designation for Tobevibar
Premium
The Fly
Vir Biotechnology gets positive opinion on orphan drug designation for Tobevibar
1M ago
Vir Biotechnology price target lowered to $26 from $28 at Barclays
PremiumThe FlyVir Biotechnology price target lowered to $26 from $28 at Barclays
2M ago
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
Premium
The Fly
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
2M ago
Vir Biotechnology Reports Q3 2024 Financial Results
Premium
Company Announcements
Vir Biotechnology Reports Q3 2024 Financial Results
2M ago
Vir Biotechnology price target raised to $28 from $27 at Barclays
PremiumThe FlyVir Biotechnology price target raised to $28 from $27 at Barclays
5M ago
Vir Biotechnology trading resumes
Premium
The Fly
Vir Biotechnology trading resumes
5M ago
Vir Biotechnology enters exclusive global license agreement with Sanofi
Premium
The Fly
Vir Biotechnology enters exclusive global license agreement with Sanofi
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100